A. Kırık Et Al. , "The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY)," 32nd European Congress on Obesity (ECO 2025) , Malaga, Spain, pp.41-42, 2025
Kırık, A. Et Al. 2025. The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY). 32nd European Congress on Obesity (ECO 2025) , (Malaga, Spain), 41-42.
Kırık, A., Sümbül, H. E., Koca, N., Konur, K., Beyazal Polat, H., & Masld Study Group, D., (2025). The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY) . 32nd European Congress on Obesity (ECO 2025) (pp.41-42). Malaga, Spain
Kırık, Ali Et Al. "The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY)," 32nd European Congress on Obesity (ECO 2025), Malaga, Spain, 2025
Kırık, Ali Et Al. "The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY)." 32nd European Congress on Obesity (ECO 2025) , Malaga, Spain, pp.41-42, 2025
Kırık, A. Et Al. (2025) . "The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY)." 32nd European Congress on Obesity (ECO 2025) , Malaga, Spain, pp.41-42.
@conferencepaper{conferencepaper, author={Ali Kırık Et Al. }, title={The prevalence of MASLD and risk of hepatic fibrosis in subjects with cardiometabolic risk factors: A nationwide study (DAHUDER MASLD STUDY)}, congress name={32nd European Congress on Obesity (ECO 2025)}, city={Malaga}, country={Spain}, year={2025}, pages={41-42} }